Pulmonology
A section of Journal of Clinical Medicine (ISSN 2077-0383).
Section Information
We take our respiratory health and breathing for granted. The human lung is a vital organ that is vulnerable to outside insults and injuries. Nothing else matters when you cannot breathe. Pulmonary diseases are a leading cause of morbidity, mortality and disability in the world. Our lungs are frequently exposed to numerous noxious agents present in the air we breathe, such as particulate matter, biomass fuel, tobacco cigarette smoking, aerosols from electronic cigarettes, heat-not-burn products (IQOS), chemicals, pesticides and respiratory pathogens. If we have a closer look at the numbers, then at least 2 billion people are exposed globally to the toxic smoke produced by the combustion of biomass fuel, inefficiently burned in poorly ventilated indoor stoves or fireplaces used for cooking or warming. One billion people inhale polluted outdoor air, and another billion are exposed primarily or secondarily to tobacco smoke, with the numbers on a steep upward trajectory. In December 2019, we saw the start of a new virus pandemic of a severe pulmonary disease, now called coronavirus disease 2019, abbreviated as “COVID-19”. The cause of COVID-19 infections is attributed to severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). As this pandemic continues to ultimately grasp the year 2020, it is imperative that respiratory health must be a top priority. There is an expeditious need to bolster research and long-term commitment to respiratory health. To promote respiratory research and dissemination, we sincerely welcome your submissions to Journal of Clinical Medicine. We welcome all submissions enhancing the understanding of pulmonary diseases and look forward to receiving your manuscripts.
Subject Areas
- COPD
- Asthma
- Pulmonary infections
- COVID-19
- Tuberculosis
- Lung cancer
- Bronchiectasis
- Cystic fibrosis
- Interstitial lung disease
- Pulmonary hypertension
- Sleep Apnea
- Rare lung diseases
- Asbestosis
- Silicosis
- Sarcoidosis
- Electronic nicotine delivery systems
- Tobacco smoking
- Air pollution
- Biomass fuel
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- Thoracic Surgery: Current and Future Strategies (Deadline: 31 March 2024)
- Obstructive Sleep Apnea (OSA): What Can We Do Now? (Deadline: 31 March 2024)
- Acute Respiratory Distress Syndrome: Causes, Diagnosis and Treatment (Deadline: 31 March 2024)
- Recent Advances in Pulmonary Embolism and Thrombosis (Deadline: 20 April 2024)
- Extracorporeal Membrane Oxygenation (ECMO): Clinical Challenges and Opportunities (Deadline: 21 April 2024)
- Prevention, Diagnosis and Treatments of Early-Stage NSCLC: New Advances and Future Prospective (Deadline: 25 April 2024)
- Review Special Issue Series: Recent Advances in Pulmonology (Deadline: 25 April 2024)
- Advances in Segmentectomy and Lobectomy of the Lung (Deadline: 30 April 2024)
- Current Advances in the Interventional Management of Central Airway Disorders (Deadline: 30 April 2024)
- Diagnosis and Management of Chronic Respiratory Diseases (Deadline: 30 April 2024)
- Enhancing Mechanical Ventilation and Lung Monitoring in Intensive Care Units: Strategies for Optimization (Deadline: 30 April 2024)
- Pneumonia and Pulmonary Infection: Clinical Insights and Treatment Strategies (Deadline: 30 April 2024)
- Clinical Advances in Interstitial Lung Diseases (Deadline: 20 May 2024)
- Recent Advances in Interstitial Lung Disease (Deadline: 20 May 2024)
- Advances in Pulmonary Rehabilitation (Deadline: 20 May 2024)
- Pulmonary Embolism: The Era of Catheter-Directed Treatment (Deadline: 24 May 2024)
- Thoracic Surgery: Current Practice and Future Directions (Deadline: 24 May 2024)
- Advances in Asthma: Volume II (Deadline: 25 May 2024)
- Clinical Diagnosis and Rehabilitation of Pulmonary Hypertension and Pulmonary Embolism (Deadline: 31 May 2024)
- An Update on the Diagnostic, Predictive and Prognostic Biomarkers of Respiratory Diseases (Deadline: 31 May 2024)
- Pediatric Pulmonary Medicine: Clinical Practices and Challenges (Deadline: 31 May 2024)
- Chronic Obstructive Pulmonary Disease (COPD): Treatment and Management (Deadline: 31 May 2024)
- Review Special Issue Series: Neoadjuvant Lung Cancer Surgery (Deadline: 12 June 2024)
- Pulmonary Embolism and Its Complications: Causes, Diagnosis and Treatment (Deadline: 16 June 2024)
- Pulmonary Disease: Treatment and Critical Care (Deadline: 20 June 2024)
- Current Challenges and Advances in Pleural Disease (Deadline: 20 June 2024)
- Clinic Advances in Non-Small-Cell Lung Cancer: Part II (Deadline: 25 June 2024)
- The Clinical Role of Imaging in Lung Diseases (Deadline: 25 June 2024)
- Biomarkers and Diagnostics in Respiratory Diseases (Deadline: 30 June 2024)
- Allergic Asthma: Causes, Diagnosis and Treatment (Deadline: 5 July 2024)
- Pulmonary Fibrosis: Therapeutic and Management Strategies (Deadline: 15 July 2024)
- Non-small Cell Lung Cancer: Current Updates and Perspectives (Deadline: 15 July 2024)
- Novel Strategies for Detection, Diagnosis and Management of Non-small Cell Lung Cancer (Deadline: 20 July 2024)
- Clinical Advances in Allergy and Asthma: Issues, Strategies, and Future Directions (Deadline: 25 July 2024)
- Diagnosis and Management of Chronic Obstructive Pulmonary Disease (COPD) (Deadline: 26 July 2024)
- Clinical Management, Diagnosis and Treatment of Thoracic Diseases (Deadline: 21 August 2024)
- Clinical Management of Acute Respiratory Distress Syndrome (Deadline: 25 August 2024)
- Chronic Obstructive Pulmonary Disease (COPD)—Clinical Aspects, Early Detection and Pathogenesis (Deadline: 26 August 2024)
- Acute Respiratory Failure: New Perspectives and Current Clinical Challenges (Deadline: 31 August 2024)
- Update on Acute Severe Respiratory Infections (Deadline: 31 August 2024)
- Innovations and Management of Cardiovascular, Respiratory, and Complex Conditions in Anesthesia and Critical Care Medicine (Deadline: 31 August 2024)
- Advances in Clinical Management of Pulmonary Arterial Hypertension (Deadline: 10 September 2024)
- Advances in Clinical Exercise, Rehabilitation and Cardiorespiratory Physiology (Deadline: 16 September 2024)
- Advances in Thoracic Oncology Multidisciplinary Care (Deadline: 20 September 2024)
- New Insights into Respiratory Diseases Caused by Substance Abuse (Deadline: 25 September 2024)
- Acute Respiratory Distress Syndrome (ARDS): Causes, Management, and Treatment (Deadline: 25 September 2024)
- Clinical Advances in Chronic Obstructive Pulmonary Disease and Its Complications: Part II (Deadline: 25 September 2024)
- Biomarkers and Lung Cancer: Clinical Application (Deadline: 30 September 2024)
- Clinical Advances in Chronic Obstructive Pulmonary Diseases in the Era of Precision Medicine (Deadline: 30 September 2024)
- Clinical Diagnosis of Lung Cancer (Deadline: 30 September 2024)
- Adult Lung Disease: Clinical Symptoms, Diagnosis, and Treatment (Deadline: 30 September 2024)
- Pulmonary Arterial Hypertension: The Unmet Needs in the Diagnosis and Therapeutic Management (Deadline: 30 October 2024)
- Emerging Paradigms in Severe Asthma Management: Integrating Technology and Personalized Treatment (Deadline: 30 October 2024)
- Pulmonary Embolism: Clinical Advances and Future Opportunities (Deadline: 31 December 2024)
- Rare Respiratory Diseases: A Personal and a Public Health Problem: 3rd Edition (Deadline: 31 January 2025)